ctrl K

Virax Biolabs Group Limit... (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

1.01

0.03 (3.06%)

At close: May 02, 2025, 3:59 PM

1.02

0.99%

After-hours: May 02, 2025, 04:38 PM EDT

Virax Biolabs Ratios and Metrics

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
PE Ratio	-0.22	-1.35	-121.14	-317.99	-258.4
PEG Ratio	0.01	-0.01	-0.74	17.12	n/a
PS Ratio	9.43	863.45	n/a	1.67K	2.07K
PB Ratio	0.27	0.81	-212.41	-347.22	-196.01
P/FCF Ratio	-0.2	-1.7	-255.86	-350.75	-278.01
P/OCF Ratio	-0.24	-1.77	-255.86	-350.75	-278.01
OCF/S Ratio	-39.94	-488.23	n/a	-4.77	-7.46
Debt / Equity Ratio	0.04	0.02	-0.00	-0.3	-0.72
Quick Ratio	25.58	10.58	0.02	0.02	0.02
Current Ratio	25.94	10.61	0.04	0.05	0.02
Asset Turnover	0.03	0.00	n/a	1.32	4.42
Interest Coverage	-241.7	-370.62	-112.3	-22.5	-7.18
Return on Equity	-1.25	-0.6	1.75	1.09	0.76
Return on Assets	-1.23	-0.56	-35.08	-6.92	-35.43
Return on Invested Capital	-1.21	-0.63	-0.02	0.01	1.55
Dividend Yield	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	0.32	-0.16	n/a	-0.08	0.46
Net Profit Margin	-43.05	-637.48	n/a	-5.26	-8.02
Pretax Profit Margin	-43.08	-637.51	n/a	-5.43	-7.4
Operating Profit Margin	-41.53	-669.64	n/a	-5.21	-6.52
FCF Margin	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	-42.25	-635.71	n/a	n/a	-6.5